ORIC Earnings & Financial Statements
ORIC Pharmaceuticals, Inc.
$11.95
-$0.06(-0.50%)
49
Overall
60
Value
63
Tech
26
Quality
Market Cap
$1.24B
Volume
1.46M
52W Range
$7.23 - $14.93
Target Price
$20.64
ORIC earnings and financial statements: ORIC Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ORIC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$143.00M | -$142.90M | -$110.78M | -$91.77M | -$78.87M |
| EBITDA | -$128.27M | -$126.75M | -$106.63M | -$85.80M | -$77.97M |
| Net income | -$129.47M | -$127.85M | -$100.70M | -$89.12M | -$78.72M |
| EPS (diluted) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $408.89M | $274.14M | $252.01M | $247.18M | $298.64M |
| Total liabilities | $24.53M | $31.02M | $27.92M | $24.83M | $25.67M |
| Shareholders’ equity | $384.36M | $243.12M | $224.09M | $222.35M | $272.98M |
| Cash and equivalents | $45.67M | $59.41M | $23.38M | $66.84M | $226.01M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$110.97M | -$112.66M | -$85.69M | -$75.14M | -$59.54M |
| Capital expenditure | -$712.0K | -$1.19M | -$849.0K | -$2.08M | -$939.0K |
| Free cash flow | -$111.68M | -$113.85M | -$86.54M | -$77.22M | -$60.48M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORIC | $11.95 | -0.5% | 1.46M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ORIC Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW